| Robert S Lind, MD | |
|
1100 Wecott Dr, Ste G3, Flemington, NJ 08822 | |
| (908) 788-1710 | |
| (908) 788-1716 |
| Full Name | Robert S Lind |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 36 Years |
| Location | 1100 Wecott Dr, Flemington, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609822782 | NPI | - | NPPES |
| 6199208 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA06067200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hunterdon Medical Center | Flemington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hunterdon Cardiovascular Associates | 3779488242 | 19 |
| Hunterdon Medical Center | 9830009711 | 73 |
News Archive
A new synthetic chemical may provide the framework for future drugs that can treat a variety of brain-based ailments, ranging from overeating and drug dependency to neuropathic pain.
Average healthcare costs for U.S. employers increased 7.3 percent in 2009, according to study published today by Thomson Reuters. The year-over-year increase topped the 2008 rate of 6.1 percent and occurred in a year when the U.S. inflation rate was negative.
Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient's tumor will be life threatening.
A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.
Researchers of the German Center for Neurodegenerative Diseases have found that "alpha-synuclein", a protein involved in a series of neurological disorders including Parkinson's disease, is capable of travelling from brain to stomach and that it does so following a specific pathway.
› Verified 3 days ago
| Entity Name | Hunterdon Cardiovascular Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053334276 PECOS PAC ID: 3779488242 Enrollment ID: O20031208000004 |
News Archive
A new synthetic chemical may provide the framework for future drugs that can treat a variety of brain-based ailments, ranging from overeating and drug dependency to neuropathic pain.
Average healthcare costs for U.S. employers increased 7.3 percent in 2009, according to study published today by Thomson Reuters. The year-over-year increase topped the 2008 rate of 6.1 percent and occurred in a year when the U.S. inflation rate was negative.
Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient's tumor will be life threatening.
A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.
Researchers of the German Center for Neurodegenerative Diseases have found that "alpha-synuclein", a protein involved in a series of neurological disorders including Parkinson's disease, is capable of travelling from brain to stomach and that it does so following a specific pathway.
› Verified 3 days ago
| Entity Name | Hunterdon Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922095116 PECOS PAC ID: 9830009711 Enrollment ID: O20040927000892 |
News Archive
A new synthetic chemical may provide the framework for future drugs that can treat a variety of brain-based ailments, ranging from overeating and drug dependency to neuropathic pain.
Average healthcare costs for U.S. employers increased 7.3 percent in 2009, according to study published today by Thomson Reuters. The year-over-year increase topped the 2008 rate of 6.1 percent and occurred in a year when the U.S. inflation rate was negative.
Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient's tumor will be life threatening.
A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.
Researchers of the German Center for Neurodegenerative Diseases have found that "alpha-synuclein", a protein involved in a series of neurological disorders including Parkinson's disease, is capable of travelling from brain to stomach and that it does so following a specific pathway.
› Verified 3 days ago
| Entity Name | Hunterdon Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841560158 PECOS PAC ID: 9830009711 Enrollment ID: O20120328000177 |
News Archive
A new synthetic chemical may provide the framework for future drugs that can treat a variety of brain-based ailments, ranging from overeating and drug dependency to neuropathic pain.
Average healthcare costs for U.S. employers increased 7.3 percent in 2009, according to study published today by Thomson Reuters. The year-over-year increase topped the 2008 rate of 6.1 percent and occurred in a year when the U.S. inflation rate was negative.
Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient's tumor will be life threatening.
A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.
Researchers of the German Center for Neurodegenerative Diseases have found that "alpha-synuclein", a protein involved in a series of neurological disorders including Parkinson's disease, is capable of travelling from brain to stomach and that it does so following a specific pathway.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert S Lind, MD 1100 Wecott Dr, Ste G3, Flemington, NJ 08822 Ph: (908) 788-1710 | Robert S Lind, MD 1100 Wecott Dr, Ste G3, Flemington, NJ 08822 Ph: (908) 788-1710 |
News Archive
A new synthetic chemical may provide the framework for future drugs that can treat a variety of brain-based ailments, ranging from overeating and drug dependency to neuropathic pain.
Average healthcare costs for U.S. employers increased 7.3 percent in 2009, according to study published today by Thomson Reuters. The year-over-year increase topped the 2008 rate of 6.1 percent and occurred in a year when the U.S. inflation rate was negative.
Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient's tumor will be life threatening.
A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.
Researchers of the German Center for Neurodegenerative Diseases have found that "alpha-synuclein", a protein involved in a series of neurological disorders including Parkinson's disease, is capable of travelling from brain to stomach and that it does so following a specific pathway.
› Verified 3 days ago
Dr. Jeffrey D Hartford, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr, Suite 201, Flemington, NJ 08822 Phone: 908-788-6504 Fax: 908-788-6458 | |
Devi Patel, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr Ste 206, Flemington, NJ 08822 Phone: 908-788-6448 Fax: 908-483-4004 | |
Daniel Kobe, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1100 Wescott Dr Ste G3, Flemington, NJ 08822 Phone: 908-788-1710 | |
Kiera Farry, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr Ste G3, Flemington, NJ 08822 Phone: 908-788-1710 | |
Dr. Mary Jean Fusco, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4 Ups N Downs Ct, Flemington, NJ 08822 Phone: 908-782-0493 | |
Donald Stuart Novy, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 6 Sand Hill Rd Ste 201, Flemington, NJ 08822 Phone: 908-237-4072 Fax: 908-782-7195 | |
Glen Erik Tonnessen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Drive, Suite G 3, Flemington, NJ 08822 Phone: 908-788-1710 Fax: 908-788-1716 |